Smith & Nephew (SNN) Competitors

GE HealthCare Technologies (NASDAQ:GEHC) and Smith & Nephew (NYSE:SNN) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, community ranking, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

Does the MarketBeat Community believe in GEHC or SNN?

Smith & Nephew received 417 more outperform votes than GE HealthCare Technologies when rated by MarketBeat users. However, 62.75% of users gave GE HealthCare Technologies an outperform vote while only 54.10% of users gave Smith & Nephew an outperform vote.

Company	Underperform	Outperform
GE HealthCare Technologies	Outperform Votes 32 62.75%	Underperform Votes 19 37.25%
Smith & Nephew	Outperform Votes 449 54.10%	Underperform Votes 381 45.90%

Is GEHC or SNN more profitable?

GE HealthCare Technologies has a net margin of 10.13% compared to Smith & Nephew's net margin of 0.00%. GE HealthCare Technologies' return on equity of 25.74% beat Smith & Nephew's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GE HealthCare Technologies	10.13%	25.74%	6.29%
Smith & Nephew	N/A	N/A	N/A

Which has better earnings and valuation, GEHC or SNN?

GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew. Smith & Nephew is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GE HealthCare Technologies	$19.80B	1.71	$1.99B	$4.75	15.56
Smith & Nephew	$5.81B	2.27	$263M	$2.16	13.92

Does the media favor GEHC or SNN?

In the previous week, GE HealthCare Technologies had 3 more articles in the media than Smith & Nephew. MarketBeat recorded 10 mentions for GE HealthCare Technologies and 7 mentions for Smith & Nephew. GE HealthCare Technologies' average media sentiment score of 1.21 beat Smith & Nephew's score of 0.75 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GE HealthCare Technologies	6 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Smith & Nephew	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders hold more shares of GEHC or SNN?

82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 25.6% of Smith & Nephew shares are owned by institutional investors. 0.3% of GE HealthCare Technologies shares are owned by insiders. Comparatively, 1.0% of Smith & Nephew shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Which has more volatility and risk, GEHC or SNN?

GE HealthCare Technologies has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. Comparatively, Smith & Nephew has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500.

Do analysts recommend GEHC or SNN?

GE HealthCare Technologies presently has a consensus price target of $88.27, suggesting a potential upside of 19.42%. Smith & Nephew has a consensus price target of $28.00, suggesting a potential downside of 6.90%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, research analysts clearly believe GE HealthCare Technologies is more favorable than Smith & Nephew.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GE HealthCare Technologies	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83
Smith & Nephew	0 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Is GEHC or SNN a better dividend stock?

GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Smith & Nephew pays an annual dividend of $0.89 per share and has a dividend yield of 3.0%. GE HealthCare Technologies pays out 2.9% of its earnings in the form of a dividend. Smith & Nephew pays out 41.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has increased its dividend for 1 consecutive years.

Summary

GE HealthCare Technologies beats Smith & Nephew on 18 of the 22 factors compared between the two stocks.